コンテンツへスキップ
Merck

Chymotrypsin C mutations in chronic pancreatitis.

Journal of gastroenterology and hepatology (2011-06-03)
Jiayi Zhou, Miklós Sahin-Tóth
要旨

Chronic pancreatitis is a persistent inflammatory disorder characterized by destruction of the pancreatic parenchyma, maldigestion, and chronic pain. Mutations in the chymotrypsin C (CTRC) gene encoding the digestive enzyme CTRC have been shown to increase the risk of chronic pancreatitis in European and Asian populations. Here, we review the biochemical properties and physiological functions of human CTRC, summarize the functional defects associated with CTRC mutations, and discuss mechanistic models that might explain the increased disease risk in carriers.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
α-キモトリプシン ウシ膵臓由来, Type II, lyophilized powder, ≥40 units/mg protein
Sigma-Aldrich
α-キモトリプシン ウシ膵臓由来, (TLCK treated to inactivate residual tryspin activity), Type VII, essentially salt-free, lyophilized powder, ≥40 units/mg protein
Sigma-Aldrich
α-キモトリプシン ウシ膵臓由来, Type I-S, essentially salt-free, lyophilized powder
Sigma-Aldrich
α-キモトリプシン ウシ膵臓由来, ≥40 units/mg protein, vial of 5 mg
Sigma-Aldrich
α-キモトリプシン ウシ膵臓由来, suitable for protein sequencing, salt-free, lyophilized powder
Sigma-Aldrich
α-キモトリプシン ヒト膵臓由来, lyophilized powder
Chymotrypsin, BRP, European Pharmacopoeia (EP) Reference Standard